Clinical Trials on Colon Adenocarcinoma in Brazil

Total 152 results

AC Camargo Cancer Center

Unknown

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers (BMACR)

Colon Cancer Stage IIb | Rectum Cancer, Adenocarcinoma | Colon Cancer Stage IIIa | Colon Cancer Stage IIIc | Colon Cancer Stage IIIb

Brazil
D'Or Institute for Research and Education
HalioDx; Diagnosticos da America SA

Recruiting

Role of Immunoscore® in Stage II-III Colorectal Cancer

Colon Adenocarcinoma

Brazil
University of Nove de Julho

Unknown

Tooth Whitening With Hydrogenperoxide in Adolescents

Posteruptive Color Change of Tooth

Brazil
AbbVie (prior sponsor, Abbott)
Genentech, Inc.

Completed

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Advanced Colorectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the Colon

United States, Australia, Belgium, Brazil, Canada, Czech Republic, Greece, Korea, Republic of, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain
Hospital Sirio-Libanes

Completed

Assessing the Agreement Between Endoscopic and Histopathological Diagnosis of Colorectal Sessile Serrated Lesions.

Colorectal Cancer | Colonoscopy | Adenoma Detection Rate | Adenoma Colon | Colorectal Polyp | Sessile Serrated Adenoma | Quality Indicator

Brazil
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

Colon Cancer | Adjuvant Chemotherapy

Brazil
Universidade Federal do Para

Completed

Whitening Efficacy and Tooth Sensitivity of Different Concentrations of Hydrogen Peroxide Photoactivated With Violet or Blue LEDs

Color | Bleaching Sensitivity

Brazil
Eloisa Andrade de Paula
Universidade Estadual de Ponta Grossa; Fundação Araucária

Completed

Effect of an Anti-inflammatory on Tooth Sensitivity Caused by Bleaching

Color Changes During Tooth Formation

Brazil
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer

Colon Cancer | Immunity | Adjuvant Chemotherapy

Brazil
Instituto do Cancer do Estado de São Paulo

Unknown

A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.

Rectal Cancer

Brazil
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bayer

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD)

Prostate Adenocarcinoma | Metastatic Prostate Adenocarcinoma | Castration-resistant

United States, Brazil
Instituto do Cancer do Estado de São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer

Thyroid Cancer, Papillary | Primary Aldosteronism

Brazil
Instituto do Cancer do Estado de São Paulo

Completed

Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.

Pancreatic Adenocarcinoma Advanced or Metastatic

Brazil
University of Sao Paulo

Active, not recruiting

SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE

Carcinoma, Hepatocellular

Brazil
University of Sao Paulo
GE Healthcare

Recruiting

PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Brazil
Hospital Sirio-Libanes

Recruiting

Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.

Hepatocellular Carcinoma

Brazil
Universidade Federal do Amazonas

Completed

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer (PRONIC-G)

Gastric Cancer | Nutritional Status | Gastric Adenocarcinoma | Cytokines | Microbiome

Brazil
Hospital de Transplante Doutor Euryclides de Jesus...

Unknown

Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.

Prostate Cancer | Prostate Adenocarcinoma | Transrectal High Intensity Focused Ultrasound

Brazil
Instituto Nacional de Ciencias Medicas y Nutricion...
University of Sao Paulo; Ethicon Endo-Surgery

Unknown

Comparative Analysis Between Bipolar Device and Conventional Tie & Suture Technique in Thyroidectomy

Papillary Thyroid Cancer | Thyroid Goiter

Mexico, Brazil
University of Sao Paulo

Completed

Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma (TheraBionic)

Advanced Hepatocellular Carcinoma

Brazil
Hospital Sao Rafael

Completed

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality (pet-ct)

Hodgkin Disease | Malignant Neoplasm of Breast | Malignant Neoplasm of Colon | Non-Hodgkin Lymphoma, Follicular (Nodular) | Malignant Neoplasm of Bronchus and Lung | Secondary Neoplasm Malignant and Unspecified Lymph Nodes | Malignant Melanoma of the Skin | Malignant Neoplasm of Small Intestine

Brazil
Instituto do Cancer do Estado de São Paulo

Recruiting

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma (STRAT-aHCC)

Hepatocellular Carcinoma | Liver Cancer

Brazil
Hospital Sirio-Libanes

Completed

Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency

Breast Cancer | Hepatocellular Carcinoma

Brazil
Instituto Nacional de Cancer, Brazil

Terminated

Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer (ICAR)

Chemoradiation | Rectal Cancer, Adenocarcinoma | Locally Advanced Malignant Neoplasm

Brazil
University of Campinas, Brazil

Terminated

Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer (NEOMETRE)

Adenocarcinoma | Carcinoma | Rectal Neoplasms

Brazil
Barretos Cancer Hospital
University of Campinas, Brazil; AC Camargo Cancer Center

Unknown

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Adenocarcinoma | Colorectal Neoplasms

Brazil
Instituto do Cancer do Estado de São Paulo
Pfizer

Unknown

Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib (SuAx)

Clear Cell Renal Cell Carcinoma

Brazil
Hospital Sirio-Libanes

Terminated

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery (HSL2012-06)

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Portal Vein Thrombosis

Brazil
Latin American Cooperative Oncology Group

Not yet recruiting

Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort

Carcinoma Adrenal | Carcinoma, Adrenocortical Recurrent

Brazil
Hospital Sirio-Libanes

Completed

Exploratory Study to Determine Tissue Alterations of Advanced Hepatocellular Carcinoma Induced by Electromagnetic Waves of Low Energy Amplitude Modulated to Specific Frequencies During Imaging Study by MRI

Primary or Metastatic Tumor in the Liver Parenchyma

Brazil
Barretos Cancer Hospital

Completed

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Kidney Cancer | Biomarkers | Gene Expression

Brazil
Hospital das Clínicas de Ribeirão Preto
Bristol-Myers Squibb; Fundação de Amparo à Pesquisa do Estado de São Paulo

Recruiting

CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy

Renal Cancer Metastatic

Brazil
Hospital Sirio-Libanes

Completed

Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma (THBC-HSL2)

Hepatitis | Hepatocellular Carcinomas

Brazil
Instituto Nacional de Cancer, Brazil

Unknown

Radiolabeled Molecules for Medullary Thyroid Cancer

Medullary Thyroid Cancer

Brazil
Hoffmann-La Roche

Completed

A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.

Colorectal Cancer

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Adenocarcinoma | Carcinoma | Uterine Cervix Adenosquamous Carcinoma

Brazil
University of Roma La Sapienza

Completed

Predictive Value of DICA in the Diverticular Disease of the Colon

Colonic Diverticula

Brazil, Italy, Lithuania, Poland, Romania, United Kingdom, Venezuela
Royal Marsden NHS Foundation Trust

Unknown

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Digestive System Diseases | Gastrointestinal Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Gastrointestinal Neoplasms | Digestive System Neoplasms | Intestinal Diseases | Colorectal Neoplasms | Intestinal Neoplasms | Rectal... and other conditions

Canada, United Kingdom, Brazil, Cyprus
Pfizer

Completed

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

Metastatic Renal Cell Carcinoma ( mRCC)

Ecuador, Argentina, Brazil, Colombia
Eisai Inc.
PharmaBio Development Inc.

Terminated

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Rectal Cancer | Colon Cancer

Argentina, Russian Federation, United States, Australia, Brazil, Ukraine
Basilea Pharmaceutica

Terminated

Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma (FIDES-03)

Gastric Adenocarcinoma

Spain, United States, Korea, Republic of, Belgium, Russian Federation, United Kingdom, Italy, France, Turkey, Germany, Poland, Brazil, Australia, Argentina, Chile
Astellas Pharma Global Development, Inc.

Active, not recruiting

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer (Spotlight)

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

United States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
Genentech, Inc.
Chugai Pharmaceutical Co.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

Gastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma

Korea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
Clovis Oncology, Inc.

Completed

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

Metastatic Pancreatic Adenocarcinoma

United States, Belgium, Canada, Australia, United Kingdom, Germany, Italy, Argentina, Russian Federation, France, Brazil, Sweden, Norway, Netherlands, Ukraine
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

Metastatic Pancreatic Ductal Adenocarcinoma

United States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
NovoCure Ltd.

Active, not recruiting

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Pancreas Adenocarcinoma

United States, China, Belgium, Czechia, Korea, Republic of, Spain, Hong Kong, France, Australia, Italy, Hungary, Germany, Croatia, Canada, Mexico, Israel, Austria, Switzerland, Brazil, Poland
Weill Medical College of Cornell University

Unknown

T-EUS for Gastrointestinal Disorders: A Multicenter Registry (EUSERCPReg)

Pancreatic Cancer | Cholangiocarcinoma | Bile Duct Cancer | Chronic Pancreatitis | Biliary Stricture | Biliary Obstruction | Ampullary Cancer | Stent Obstruction | Proximal Duct Stricture | Distal Duct Stricture | Biliary Sphincter Stenosis | Impacted Stones | Peri-ampullary Diverticula | Altered Anatomy

United States, Brazil
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

Colorectal Cancer

Italy, Spain, Australia, Switzerland, United States, Germany, Canada, Austria, United Kingdom, Israel, Brazil, Portugal, Belgium, Argentina
Bayer

Completed

Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib (OPTIMIS)

Carcinoma, Hepatocellular

Japan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
Arcus Biosciences, Inc.
Gilead Sciences; Taiho Pharmaceutical Co., Ltd.

Recruiting

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body (STAR-221)

Advanced Upper Gastrointestinal Tract Adenocarcinoma

United States, France, Spain, Korea, Republic of, Hungary, Israel, United Kingdom, Italy, Japan, China, Australia, Canada, Portugal, Romania, Hong Kong, Malaysia, Argentina, Georgia, Serbia, Lithuania, Mexico, Chile, Greece, Guatemala, ... and more

Clinical Trials on Colon Adenocarcinoma in Brazil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations